The hazard
CGMP: Due to Out of Specification (OOS) result for N-Nitroso Mirabegron impurity.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Mirabegron Extended-Release Tablets, 25 mg, 30-count bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Matoda, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1159-3.
- Brand / company
- Zydus Pharmaceuticals (USA) Inc
- Codes / lots
- Lot # E408618, Expiry: 11/30/2026, NDC #: 70710-1159-3
- Distribution
- Nationwide in the USA
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 12 Aug 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.